🔎 Trials Near Me

Utama › Leukemia Mieloid Akut › Colorado › Denver

Kajian klinikal Leukemia Mieloid Akut di Denver, CO

12 kajian untuk Leukemia Mieloid Akut sedang mencari peserta di lokasi dalam dan sekitar Denver (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
  • AdventHealth Porter, Denver
Umur 40 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05334069

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Mengambil pesertaFasa 3
  • Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center, Denver
6 Months – 21 Years · Semua jantina · Dikemas kini 17 Sep 2026 · NCT04293562

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia

Mengambil pesertaFasa 3
  • Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center, Denver
Umur 1 hingga 25 · Semua jantina · Dikemas kini 4 Sep 2026 · NCT07022678

CER-1236 in Patients With Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), and Myelofibrosis (MF)

Mengambil pesertaFasa 1
  • Colorado Blood Cancer Institute, Denver
Umur 18 hingga 85 · Semua jantina · Dikemas kini 26 Ogo 2026 · NCT06834282

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Mengambil pesertaFasa 1/2
  • Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center, Denver
Sehingga umur 22 · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT04726241

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Mengambil pesertaFasa 3
  • Colorado Blood Cancer Institute, Denver
Umur 18 ke atas · Semua jantina · Dikemas kini 20 Ogo 2026 · NCT07007312

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Mengambil pesertaFasa 1
  • Colorado Blood Cancer Institute, Denver
Umur 18 ke atas · Semua jantina · Dikemas kini 20 Ogo 2026 · NCT06001788

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Mengambil pesertaKajian pemerhatian
  • Presbyterian St. Luke's/Colorado Blood Cancer Institute, Denver
Semua umur · Semua jantina · Dikemas kini 6 Jul 2026 · NCT01351545

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Mengambil pesertaFasa 1/2
  • Colorado Blood Cancer Institute, Denver
Umur 12 ke atas · Semua jantina · Dikemas kini 24 Mac 2026 · NCT04988555

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Mengambil pesertaFasa 1
  • Colorado Blood Cancer Institute, Denver
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Mac 2026 · NCT05735184

Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia

Mengambil pesertaSukarelawan sihat dialu-alukan
  • University of Colorado Denver I Anschutz Medical Campus, Denver
Umur 18 hingga 120 · Semua jantina · Dikemas kini 25 Jul 2025 · NCT05237258

APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML

Mengambil pesertaFasa 1
  • Colorado Blood Cancer Institute, Denver
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Mei 2025 · NCT06634394

Kajian Leukemia Mieloid Akut di bandar lain

Kajian lain di Denver

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.